Maria Mercedes
Maria Mercedes Castro-Cabado, Madrid ES
Patent application number | Description | Published |
---|---|---|
20150321958 | FORMALDEHYDE-FREE BINDER AND USE FOR MINERAL WOOL INSULATION PRODUCTS - The present invention relates to a new formaldehyde-free binder composition for mineral wool products, wherein the binder composition is an aqueous composition containing starch, wherein an amount of 95 weight % or more of the starch is water-insoluble native starch, and an acrylic component. The present invention also relates to the use of this formaldehyde-free binder composition in the manufacturing of mineral wool insulation products. Finally, the present invention relates to a process for manufacturing the formaldehyde-free binder composition wherein a dispersion of starch, wherein an amount of 95 weight % or more of the starch is water-insoluble native starch, is brought in contact with the acrylic component at a temperature of not higher than 40° C. | 11-12-2015 |
Maria Mercedes Delgado Mederos, San Diego, CA US
Patent application number | Description | Published |
---|---|---|
20090023724 | Heteroaryl compounds, compositions thereof, and methods of treatment therewith - Provided herein are Heteroaryl Compounds having the following structure: | 01-22-2009 |
20090042890 | Heteroaryl compounds, compositions thereof, and methods of treatment therewith - Provided herein are Heteroaryl Compounds having the following structure: | 02-12-2009 |
20090275564 | HALOARYL SUBSTITUTED AMINOPURINES, COMPOSITIONS THEREOF, AND METHODS OF TREATMENT THEREWITH - Provided herein are Aminopurine Compounds having the following structure: | 11-05-2009 |
20090312320 | METHODS OF TREATMENT COMPRISING THE ADMINISTRATION OF HALOARYL SUBSTITUTED AMINOPURINES OR COMPOSITIONS THEREOF - Provided herein are Aminopurine Compounds having the following structure: | 12-17-2009 |
20110224217 | METHODS OF TREATMENT USING HETEROARYL COMPOUNDS AND COMPOSITIONS THEREOF - Provided herein are Heteroaryl Compounds having the following structure: | 09-15-2011 |
20110245245 | METHODS OF TREATMENT COMPRISING THE ADMINISTRATION OF HETEROARYL COMPOUNDS - Provided herein are Heteroaryl Compounds having the following structure: | 10-06-2011 |
Maria Mercedes Faro Tomas, Sabadell ES
Patent application number | Description | Published |
---|---|---|
20090176709 | PROCESS FOR OBTAINING A CONCENTRATE OF VON WILLEBRAND FACTOR OR A COMPLEX OF FACTOR VIII/VON WILLEBRAND FACTOR AND USE OF THE SAME - The process is characterised by the preparation of a solution of Von Willebrand Factor or a complex of Factor VIII/Von Willebrand Factor which contains VWF and a concentration of up to 12 IU VWF:RCo/ml and a Von Willebrand Factor/Factor VIII ratio of 0.4 or more; and then proceeding with nanofiltration of the solution prepared in a) through a filter having a pore size of less than 35 nanometres. | 07-09-2009 |
20110275570 | PROCESS FOR OBTAINING A CONCENTRATE OF VON WILLEBRAND FACTOR OF A COMPLEX OF FACTOR VIII/VON WILLEBRAND FACTOR AND USE OF THE SAME - A method of treating a patient suffering from Haemophilia A and/or Von Willebrand's disease involves administering the patient a concentrate of Von Willebrand Factor (VWF) or a complex of Factor VIII/VWF prepared by creating a solution of VWF or a complex of Factor VIII/VWF containing VWF at a concentration of up to 12 IU VWF:RCo/ml and a VWF/Factor VIII ratio of 0.4 or more, and nanofiltering that starting solution through a filter of pore size of about 35 nm or smaller. The resulting VWF retains high molecular weight multimers. | 11-10-2011 |
Maria Mercedes Ferreras Gomez, Lyngby DK
Patent application number | Description | Published |
---|---|---|
20090258377 | Method of Measuring Enzymatic Activity of Adsorbed Allergenic Enzyme - The invention relates to a method of measuring the immunological activity of a vaccine preparation in the form of a mixture of one or more allergenic enzyme(s) and an oxygen-containing metal salt adjuvant, wherein the mixture comprises a liquid phase and a solid phase, and wherein at least a part of the allergenic enzyme(s) is adsorbed to the solid phase, the method comprising the steps of measuring the enzymatic activity of the mixture in an enzyme activity assay, and using the measurement obtained as an indication of the immunological activity of the vaccine preparation, or using the measurement obtained for quantifying the amount of allergenic enzyme. | 10-15-2009 |
Maria Mercedes Ferreras Gomez, Kgs. Lyngby DK
Patent application number | Description | Published |
---|---|---|
20100291155 | ALLERGY VACCINE COMPOSITION FOR MUCOSAL ADMINISTRATION - The present invention relates to an allergy vaccine composition for mucosal administration comprising a cysteine protease allergen in a reduced active state or in an oxidised inactive state, The inventions further relates to an adjuvant system for use in a vaccine for mucosal administration comprising a cysteine protease. | 11-18-2010 |
Maria Mercedes González Hormaizteguy, Montevideo UY
Patent application number | Description | Published |
---|---|---|
20120035160 | NEW FAMILY OF ANTICHAGASICS DERIVED FROM IMIDAZO[4,5-C][1,2,6]THIADIAZINE 2,2-DIOXIDE - Compounds derived from imidazo[4,5-c][1,2,6]thiadiazine 2,2-dioxides, for use as a drug or pharmaceutical composition for treatment of parasitic diseases, preferably of diseases caused by parasites of the | 02-09-2012 |
Maria Mercedes Ramos Gonzalez, Madrid ES
Patent application number | Description | Published |
---|---|---|
20100048464 | Bioactive peptides identified in enzymatic hydrolyzates of milk caseins and method of obtaining same - The invention relates to the production of bioactive products that are derived from milk proteins for the production of bioactive milk products derived from milk proteins, particularly caseins. The 16 inventive peptides can be obtained chemically, biotechnologically or by means of enzymatic treatment from proteins containing same and give rise to peptides with an antimicrobial activity, an in vitro angiotensin converter inhibitor activity and/or antihypertensive activity and/or antioxidant activity. Said nutraceutical products are suitable for use in the food and pharmaceutical industries, both in the form of a hydrolyzate or bioactive peptides. | 02-25-2010 |